(OMER - Get Report)
This is a clinical-stage biopharmaceutical company. It is engaged in discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system. This stock is trading up 9% at $11.48.
Today's Volume: 187,000
Average Volume: 151,419
Volume % Change: 144%
From a technical perspective, OMER is ripping higher here on above-average volume, and the stock has started to trigger a major breakout trade above some past overhead resistance at $10.88. This move has now pushed OMER into new 52-week high territory. Traders should continue to look for long-biased trades as long as OMER is trending above $10.88 with strong upside volume flows.
I would consider any upside volume day that registers near or above 151,419 as bullish. If we continue to see that action, then OMER has a great chance of hitting $15 in the near future. On the flipside, I would avoid any long trades if OMER cannot hold its trend over $10.88 with strong volume flows.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts